Among the 36 NTHL1 biallelic carriers, 29 (80.6%) were diagnosed with CRC and/or another type of cancer at a median age of 47 years (range: 24–67) at first diagnosis and 18 of them (62.1%) showed an early age of onset (<50 years). Here, NTHL1 is linked to cancer.